The effectiveness of some pesticides in the control of thrips and red spider mites on strawberry plants

This study was carried out in a private farm in Wardan, Giza governorate in Egypt during 2019 season on strawberry plants. The first experiment aimed to evaluate the effectiveness of different commercial products in cultivated land including Solo 24% SC (Bifenazate), Arbus 12% SC (Chlorfenapyr + Emamectin benzoate) , Concor 24% SC (Spirodiclofen), Excellent 1.9% EC (Emamectin benzoate) , Top9 (Chitosan 0.1%) , Biomectin 5% EC (Abamectin) and Congest 15% CS (Abamectin + Imidacloprid) in reducing the population densities of two spotted spider mite, Tetranychus uriticae Koch. on strawberry plants. According to general mean percentage of reduction in population of T. uriticae, data showed insignificant differences among the seven tested compounds whereas the mortality percentages were 85.94 %, 82.18%, 81.4%, 79.36%, 78.14%, 77.94% and 75.9%, respectively. From these results; it’s clear that Solo compound is the most effective compound and Congest is the lowest one. The other compounds ranged between them in controlling T. uriticae under these experimental conditions. The second experiment evaluated the effectiveness of different formulations in the nursery including Radiant (Spinetoram 12% Sc), Super Rigo (Naphthyl acetic acid – Chitosan), Top9 and Berna Star (Glyceryl stearate 32%) in reducing the population densities of western flower thrips, Frankliniella occidentalis (Pergande) on strawberry plants. According to general mean percentage of reduction in population of F. occidentalis, data showed significant differences among the four compounds. These compounds could be divided into three groups. The first group contained Radiant compound showing high mortality (63.5%). The second group contained Super Rigo and Top9 compounds showing moderate effect (46.44% & 34.3%), respectively. The third group contained Berna Star compound showing least effect (28.36%). From these results; it’s clear that the chemical compound Radiant is the most effective while the natural compound Berna Star is the lowest in controlling F. occidentalis under these experimental conditions

Glucose metabolism abnormalities among pediatric acute lymphoblastic leukemia survivors: Assessment and relation to body mass index and waist to hip ratio

AbstractBackgroundAs survival rates of pediatric acute lymphoblastic leukemia (ALL) improve, attention is turning to side and late effects of therapy including glucose metabolism abnormalities.ObjectiveTo asses the presence of abnormal glucose metabolism in pediatric ALL survivors and its possible relation to body mass index (BMI), waist to hip ratio and treatment related factors.Subjects and methodsRetrospective study with a prospective follow-up of 12 ALL survivors who had been off chemotherapy for >9months was done. Fifteen healthy sex and age matched children were involved as controls. Body mass index (BMI) waist to hip ratio (WHR), and Oral glucose tolerance test (OGTT) were performed with assessment of glycated hemoglobin (Hb A1C) and insulin sensitivity indices.ResultsAt study time the mean BMI, WHR, all components of the OGTT (except the 2h post load glucose), all indices of insulin sensitivity and the mean Hb A1C% were significantly higher compared to those of the controls. Two survivors (16.6%) developed transient hyperglycemia during therapy, one (8.3%) had pre-diabetes, seven (58.3%) had a risk level of Hb A1C but no one had diabetes mellitus (DM) or insulin resistance (IR). At study time the two survivors with transient hyperglycemia during therapy had a significantly high WHR compared to the remainders. WHR of the survivors at study time correlated significantly with fasting plasma glucose and area of insulin under the curve (AUC). The 2h post-prandial plasma glucose correlated with the duration after therapy completion.ConclusionsWHR may play a better role than BMI in the prediction of insulin resistance in those patients. Hb A1C may increase earlier than other indices of glucose tolerance

Novel, Functional Fermented Dairy Product: Preparation and Evaluation of Dried Kishk-like Products from Fenugreek Seeds with Cow’s Milk, Camel’s Milk, and Goat’s Milk

The objective of this study was to evaluate the nutritional value of dried Kishk-like products using burghal of wheat, oat, and fenugreek with cow’s milk, camel’s milk, and goat’s milk. Kishk is an artisanal product that is popular in Egypt and the Middle East. This product is made primarily with wheat; however, to our knowledge, no research has used fenugreek seeds in making it. Changes in the physicochemical, microbial, and sensory properties of Kishk samples were followed over 90 days of storage at room temperature. The proximate analysis of fenugreek–Kishk samples (CF, AF, and GF) revealed the levels of moisture content (4.05–7.86%), protein (21.49–22.66%), fat (22.07–26.07%), fiber (13.59–14.19%), carbohydrate (22.16–28.37%), and ash (8.00–9.03%), and acidity ranged from 3.00% to 5.98%. Notably, the GF sample displayed the highest a*, b*, dC*, and ΔE values, along with the lowest L* value among all samples. Counts of coliform, yeasts and molds, Staphylococci, and spore-forming bacteria were not detected at detection limit < log CFU/g for any prepared Kishk-like samples. This was due to the combined levels of organic acids, high acidity, and low moisture content in Kishk samples that resulted in a safe food with a long shelf life. The Kishk-like samples thus could provide a complementary diet for infants up to six months, as well as a suitable option for children and elderly individuals requiring specialized care, offering an alternative to commercially available extracts

Flow behavior and mechanical properties of multi-pass thermomechanically processed 7075 Al-alloy

Research on multi-pass hot processing of 7075 Al-alloy was rarely discussed. This study aims to design and evaluate different thermomechanical processing strategies (TMPS) to produce 3 mm-thick sheets of 7075 Al-alloy. A physical simulation was performed using the hot compression test of a Gleeble 3500 to study flow mechanisms and microstructural evolution, while an experimental investigation was carried out using a rolling mill to examine the effect of TMPS on the mechanical properties. Four hot forming strategies were designed and tested at a constant strain rate of 0.1 s−1 over a temperature range of 200–450 °C. These strategies involved applying a constant amount of deformation of 65–70% in single (SP), double (DP), triple (TP), and quadruple (QP) passes of thermomechanical processing to study the influence of multi-pass thermomechanical processing on the final mechanical properties and industrial feasibility. The microstructure analysis showed a significant refinement and more uniform distribution of precipitates with an increasing number of passes, as observed through optical micrographs and the full width at half maximum (FWHM)-position relationship of XRD data. The results indicate that QP is the optimum strategy for producing the best mechanical properties in the shortest production time

Critically ill patients with diabetes and Middle East respiratory syndrome:a multi-center observational study

Background: Diabetes is a risk factor for infection with coronaviruses. This study describes the demographic, clinical data, and outcomes of critically ill patients with diabetes and Middle East Respiratory Syndrome (MERS).Methods: This retrospective cohort study was conducted at 14 hospitals in Saudi Arabia (September 2012–January 2018). We compared the demographic characteristics, underlying medical conditions, presenting symptoms andsigns, management and clinical course, and outcomes of critically ill patients with MERS who had diabetes compared to those with no diabetes. Multivariable logistic regression analysis was performed to determine ifdiabetes was an independent predictor of 90-day mortality.Results: Of the 350 critically ill patients with MERS, 171 (48.9%) had diabetes. Patients with diabetes were more likely to be older, and have comorbid conditions, compared to patients with no diabetes. They were more likely topresent with respiratory failure requiring intubation, vasopressors, and corticosteroids. The median time to clearance of MERS-CoV RNA was similar (23 days (Q1, Q3: 17, 36) in patients with diabetes and 21.0 days (Q1, Q3: 10, 33) in patients with no diabetes). Mortality at 90 days was higher in patients with diabetes (78.9% versus 54.7%, p &lt;0.0001). Multivariable regression analysis showed that diabetes was an independent risk factor for 90-day mortality(odds ratio, 2.09; 95% confidence interval, 1.18–3.72).Conclusions: Half of the critically ill patients with MERS have diabetes; which is associated with more severe disease. Diabetes is an independent predictor of mortality among critically patients with MERS

Critically ill patients with diabetes and Middle East respiratory syndrome:a multi-center observational study

Background: Diabetes is a risk factor for infection with coronaviruses. This study describes the demographic, clinical data, and outcomes of critically ill patients with diabetes and Middle East Respiratory Syndrome (MERS).Methods: This retrospective cohort study was conducted at 14 hospitals in Saudi Arabia (September 2012–January 2018). We compared the demographic characteristics, underlying medical conditions, presenting symptoms andsigns, management and clinical course, and outcomes of critically ill patients with MERS who had diabetes compared to those with no diabetes. Multivariable logistic regression analysis was performed to determine ifdiabetes was an independent predictor of 90-day mortality.Results: Of the 350 critically ill patients with MERS, 171 (48.9%) had diabetes. Patients with diabetes were more likely to be older, and have comorbid conditions, compared to patients with no diabetes. They were more likely topresent with respiratory failure requiring intubation, vasopressors, and corticosteroids. The median time to clearance of MERS-CoV RNA was similar (23 days (Q1, Q3: 17, 36) in patients with diabetes and 21.0 days (Q1, Q3: 10, 33) in patients with no diabetes). Mortality at 90 days was higher in patients with diabetes (78.9% versus 54.7%, p &lt;0.0001). Multivariable regression analysis showed that diabetes was an independent risk factor for 90-day mortality(odds ratio, 2.09; 95% confidence interval, 1.18–3.72).Conclusions: Half of the critically ill patients with MERS have diabetes; which is associated with more severe disease. Diabetes is an independent predictor of mortality among critically patients with MERS

BM-MSCs alleviate diabetic nephropathy in male rats by regulating ER stress, oxidative stress, inflammation, and apoptotic pathways

Introduction: Diabetic nephropathy (DN), a chronic kidney disease, is a major cause of end-stage kidney disease worldwide. Mesenchymal stem cells (MSCs) have become a promising option to mitigate several diabetic complications.Methods: In this study, we evaluated the therapeutic potential of bone marrow-derived mesenchymal stem cells (BM-MSCs) in a rat model of STZ-induced DN. After the confirmation of diabetes, rats were treated with BM-MSCs and sacrificed at week 12 after treatment.Results: Our results showed that STZ-induced DN rats had extensive histopathological changes, significant upregulation in mRNA expression of renal apoptotic markers, ER stress markers, inflammatory markers, fibronectin, and intermediate filament proteins, and reduction of positive immunostaining of PCNA and elevated P53 in kidney tissue compared to the control group. BM-MSC therapy significantly improved renal histopathological changes, reduced renal apoptosis, ER stress, inflammation, and intermediate filament proteins, as well as increased positive immunostaining of PCNA and reduced P53 in renal tissue compared to the STZ-induced DN group.Conclusion: In conclusion, our study indicates that BM-MSCs may have therapeutic potential for the treatment of DN and provide important insights into their potential use as a novel therapeutic approach for DN

Impact of opioid-free analgesia on pain severity and patient satisfaction after discharge from surgery: multispecialty, prospective cohort study in 25 countries

Background: Balancing opioid stewardship and the need for adequate analgesia following discharge after surgery is challenging. This study aimed to compare the outcomes for patients discharged with opioid versus opioid-free analgesia after common surgical procedures.Methods: This international, multicentre, prospective cohort study collected data from patients undergoing common acute and elective general surgical, urological, gynaecological, and orthopaedic procedures. The primary outcomes were patient-reported time in severe pain measured on a numerical analogue scale from 0 to 100% and patient-reported satisfaction with pain relief during the first week following discharge. Data were collected by in-hospital chart review and patient telephone interview 1 week after discharge.Results: The study recruited 4273 patients from 144 centres in 25 countries; 1311 patients (30.7%) were prescribed opioid analgesia at discharge. Patients reported being in severe pain for 10 (i.q.r. 1-30)% of the first week after discharge and rated satisfaction with analgesia as 90 (i.q.r. 80-100) of 100. After adjustment for confounders, opioid analgesia on discharge was independently associated with increased pain severity (risk ratio 1.52, 95% c.i. 1.31 to 1.76; P &lt; 0.001) and re-presentation to healthcare providers owing to side-effects of medication (OR 2.38, 95% c.i. 1.36 to 4.17; P = 0.004), but not with satisfaction with analgesia (beta coefficient 0.92, 95% c.i. -1.52 to 3.36; P = 0.468) compared with opioid-free analgesia. Although opioid prescribing varied greatly between high-income and low- and middle-income countries, patient-reported outcomes did not.Conclusion: Opioid analgesia prescription on surgical discharge is associated with a higher risk of re-presentation owing to side-effects of medication and increased patient-reported pain, but not with changes in patient-reported satisfaction. Opioid-free discharge analgesia should be adopted routinely

Enhanced Oil Recovery: Chemical Flooding

The enhanced oil recovery phase of oil reservoirs production usually comes after the water/gas injection (secondary recovery) phase. The main objective of EOR application is to mobilize the remaining oil through enhancing the oil displacement and volumetric sweep efficiency. The oil displacement efficiency enhances by reducing the oil viscosity and/or by reducing the interfacial tension, while the volumetric sweep efficiency improves by developing a favorable mobility ratio between the displacing fluid and the remaining oil. It is important to identify remaining oil and the production mechanisms that are necessary to improve oil recovery prior to implementing an EOR phase. Chemical enhanced oil recovery is one of the major EOR methods that reduces the residual oil saturation by lowering water-oil interfacial tension (surfactant/alkaline) and increases the volumetric sweep efficiency by reducing the water-oil mobility ratio (polymer). In this chapter, the basic mechanisms of different chemical methods have been discussed including the interactions of different chemicals with the reservoir rocks and fluids. In addition, an up-to-date status of chemical flooding at the laboratory scale, pilot projects and field applications have been reported